According to a recent article in News-Medical.net, the Sunshine Act’s new Open Payments plan could potentially be the cause of a dramatic downfall in U.S. clinical research. Research conducted from the U.S. Open Payments database has shown that between 2013 and 2014, clinical research spending has declined 32%, with nearly $500 million less spent. While the Open Payments program was designed to create transparency regarding healthcare finances, such transparency may be hurting rather than helping some activities such as research. To read the full article, click here.